Business Standard

Friday, December 20, 2024 | 04:28 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

France plans 2nd Covid-19 booster dose for adults aged 18-59: Report

France will offer a second Covid-19 booster jab to at-risk adults aged from 18 to 59, as well as pregnant women and those who live with vulnerable or immunocompromised people, Le Parisien reported

UK booster dose

Photo: Bloomberg

ANI Europe

France will offer a second COVID-19 booster jab to at-risk adults aged from 18 to 59, as well as pregnant women and those who live with vulnerable or immunocompromised people, the French newspaper Le Parisien reported Wednesday.

This newly enlarged vaccination campaign will target around five million people, it said.

The second booster is administered with Pfizer/BioNTech and Moderna vaccines at least three months after the first booster shot, or after six months for those aged over 80.

Last week, the French national health authority HAS recommended a second booster dose to adults under 60 who were "identified as being at risk of a severe form of COVID-19."

 

"You have to get vaccinated now, without waiting for new vaccines, to be protected from the risk of a severe form," the Ministry of Health told the public on Wednesday.

The HAS's recommendation was based on the spread of Omicron subvariants BA.4 and BA.5, as well as the weak progression of the first booster dose.

France started to offer a second booster dose to people aged over 80 on March 14 and to those over 60 on April 7.

According to the country's public health agency, 79 per cent of the population are fully vaccinated and 59.5 per cent have received a booster shot.

On Wednesday, France reported 89,982 new COVID-19 cases in 24 hours.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jul 21 2022 | 6:33 AM IST

Explore News Home